Identification of a novel blaOXA-51 variant, blaOXA-92, from a clinical isolate of Acinetobacter baumannii [2]

Clinical Microbiology and Infection

Volumn 13, Issue 3, 2007, Pages 348-349

  Tsakris, A ^a   Ikonomidis, A ^b   Spanakis, N ^a   Pournaras, S ^b   Bethimouti, K ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c RED CROSS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; IMIPENEM; MEROPENEM;

ACINETOBACTER BAUMANNII; ALLELE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; GENE SEQUENCE; HOSPITALIZATION; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ACINETOBACTER BAUMANNII;

EID: 34247254453     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01598.x     Document Type: Letter

References (11)

1. Brown S, Young HK, Amyes SGB. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 2005; 11: 15-23.
2. Brown S, Amyes SGB. The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents. Clin Microbiol Infect 2005; 11: 326-329.
3. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-836.
4. Turton JF, Ward ME, Woodford N et al. The role of IS Aba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258: 72-77.
5. Héritier C, Poirel L, Fournier P-E, Claverie J-M, Raoult D, Nordmann P. Characterisation of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 4174-4179.
6. Pournaras S, Markogiannakis A, Ikonomidis A et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. J Antimicrob Chemotherapy 2006; 57: 557-5561.
7. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005; 49: 4485-4491.
8. Vahaboglu H, Budak F, Kasap M et al. High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: Co-existence with OXA-58 in multiple centres. J Antimicrob Chemother 2006; 58: 537-542.
9. Woodford N, Ellington MJ, Coelho JM et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351-353.
10. Brown S, Amyes S. OXA β-lactamases in Acinetobacter: The story so far. J Antimicrob Chemother 2006; 57: 1-3.
11. Tsakris A, Ikonomidis A, Pournaras S et al. VIM-1 metallo-β-lactamase in Acinetobacter baumannii. Emerg Infect Dis 2006; 12: 981-983.